Why the study?
Cardio-oncology patients face an increased risk of COVID-19 infection and severe complications, presenting difficulties in diagnosing complications and balancing clinical care against exposure risks.
This expert consensus provides a framework for balancing the risks of COVID-19 exposure against the need for ongoing cardiovascular surveillance and treatment in cardio-oncology patients.
Guides clinicians in balancing COVID-19 exposure with cardiac monitoring in cancer patients; extends prior cardio-oncology consensus to pandemic settings.
In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history and with or at risk of cardiovascular disease-are a rapidly growing population who are at increased risk of infection, and experiencing severe and/or lethal complications by COVID-19. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, and pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic.
No takes yet. Share an insight, caveat, or question.
Baldassarre et al. (2020) conducted a review in Cancer and cardiovascular disease during COVID-19. Cardiovascular care and imaging modifications was evaluated. Expert consensus recommendations outline strategies for optimizing cardiovascular screening, multimodality imaging, and treatment modifications for cardio-oncology patients during the COVID-19 pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: